We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




High Malaria Parasitemia Affects Rapid Diagnostic Tests

By LabMedica International staff writers
Posted on 26 Jul 2010
Rapid diagnostic tests (RDTs) for malaria are devices that detects malaria antigen in a small amount of blood. More...
Monoclonal antibodies directed against the target parasite antigen are impregnated on a test strip.

A small amount of finger prick blood is put on the immunochromatographic strip and the result, usually a colored test line, is obtained in 5-20 minutes. RDTs require no capital investment or electricity, are simple to perform, and are easy to interpret.

Most malaria RDTs detect Plasmodium falciparum, and an antigen common to all four species. Plasmodium vivax-specific RDTs target P. vivax-specific parasite lactate dehydrogenase (Pv-pLDH). P. falciparum parasites cause the fatal form of malaria and patients may need hospitalization, while P. vivax and the other species are more benign.

RDTs are widely used in both the developed and developing world and they are replacing the traditional methods that require highly trained and skilled microscopists. In a recent study, nine P. vivax specific RDTs were tested with blood from 85 patients with P. falciparum whose parasite density was equal or greater than 2%. The RDTs included two-band (detecting Pv-pLDH), three-band (detecting P. falciparum-antigen and Pv-pLDH) and four-band RDTs (detecting P. falciparum, Pv-pLDH and pan-pLDH). False positive Pv-pLDH lines were observed in six of the nine RDTs, including two- three- and four-band RDTs. They occurred in the individual RDT brands at frequencies ranging from 8.2% to 29.1%. Over 22% of samples generated a false positive Pv-pLDH line at least two RDT brands. False positive lines were of medium or strong line intensity in 18% of the samples.

False positive Pv-pLDH lines in P. falciparum samples with high parasite density occurred in six of the nine P. vivax-specific RDTs. This is of concern, as both malarial parasites are cocirculating in many regions. The diagnosis of life-threatening P. falciparum malaria may be missed (two-band Pv-pLDH RDT), or the patient may be treated incorrectly with primaquine (three- or four-band RDTs) which may cause hemolysis in patients with glucose-6 phosphate dehydrogenase (G6PD) deficiency.

As batch lots of RDTs are variable in their specificity, the authors of the study did not give manufactures details, which were chosen from the World Health Organization's (WHO; Geneva, Switzerland) list of recommended kits. The results of the study were published in the July 2010 issue of the Malaria Journal.

Related Links:
WHO




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.